Market-Moving News for November 18th
Market-Moving News for November 18th
RGNX: 30% | REGENXBIO shares are trading higher after the company announced dosing the first patient in its pivotal trial for Duchenne gene therapy.
RGNX: 30% | regenxbio股票交易价格上涨，因为该公司宣布对杜欠氏肌营养不良基因治疗的关键试验中第一位患者进行了投药。
NIVF: 123% | NewGenIvf Inks Binding Term Sheet With California-Based Institutional Investor White Lion Capital, LLC, For $100M Equity Line Of Credit, Expandable To $500M
NIVF: 123% | NewGenIvf与加州机构投资公司White Lion Capital, LLC签署了10000万美元的股权授信框架协议，可扩大至5亿美元。
ALDX: 10% | Aldeyra Therapeutics shares are trading higher after the FDA accepted its resubmitted new drug application for Reproxalap for the treatment of dry eye disease, prompting the company to announce an expansion of its option agreement with AbbVie.
ALDX: 10% | aldeyra therapeutics股票交易价格上涨，因为美国食品药品监督管理局接受了其重新提交的关于Reproxalap治疗干眼症的新药申请，促使该公司宣布扩大与艾伯维公司的期权协议。
